Literature DB >> 20812286

Multimodality imaging techniques.

Luis Martí-Bonmatí1, Ramón Sopena, Paula Bartumeus, Pablo Sopena.   

Abstract

In multimodality imaging, the need to combine morphofunctional information can be approached by either acquiring images at different times (asynchronous), and fused them through digital image manipulation techniques or simultaneously acquiring images (synchronous) and merging them automatically. The asynchronous post-processing solution presents various constraints, mainly conditioned by the different positioning of the patient in the two scans acquired at different times in separated machines. The best solution to achieve consistency in time and space is obtained by the synchronous image acquisition. There are many multimodal technologies in molecular imaging. In this review we will focus on those multimodality image techniques more commonly used in the field of diagnostic imaging (SPECT-CT, PET-CT) and new developments (as PET-MR). The technological innovations and development of new tracers and smart probes are the main key points that will condition multimodality image and diagnostic imaging professionals' future. Although SPECT-CT and PET-CT are standard in most clinical scenarios, MR imaging has some advantages, providing excellent soft-tissue contrast and multidimensional functional, structural and morphological information. The next frontier is to develop efficient detectors and electronics systems capable of detecting two modality signals at the same time. Not only PET-MR but also MR-US or optic-PET will be introduced in clinical scenarios. Even more, MR diffusion-weighted, pharmacokinetic imaging, spectroscopy or functional BOLD imaging will merge with PET tracers to further increase molecular imaging as a relevant medical discipline. Multimodality imaging techniques will play a leading role in relevant clinical applications. The development of new diagnostic imaging research areas, mainly in the field of oncology, cardiology and neuropsychiatry, will impact the way medicine is performed today. Both clinical and experimental multimodality studies, in humans and animals, will have to demonstrate an efficient use of the imaging information provided by the modalities to affect the future of medical imaging.

Entities:  

Mesh:

Year:  2010        PMID: 20812286     DOI: 10.1002/cmmi.393

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  23 in total

1.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

2.  In vivo pentamodal tomographic imaging for small animals.

Authors:  Muhan Liu; Hongbo Guo; Hongbo Liu; Zeyu Zhang; Chongwei Chi; Hui Hui; Di Dong; Zhenhua Hu; Jie Tian
Journal:  Biomed Opt Express       Date:  2017-02-06       Impact factor: 3.732

3.  "RADIOTRANSCRIPTOMICS": A synergy of imaging and transcriptomics in clinical assessment.

Authors:  Amal Katrib; William Hsu; Alex Bui; Yi Xing
Journal:  Quant Biol       Date:  2016-03-04

Review 4.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

5.  3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse.

Authors:  Rebecca L Acabchuk; Ye Sun; Richard Wolferz; Matthew B Eastman; Jessica B Lennington; Brett A Shook; Qian Wu; Joanne C Conover
Journal:  J Vis Exp       Date:  2015-05-19       Impact factor: 1.355

Review 6.  Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects.

Authors:  Mia Karam; Duaa Fahs; Batoul Maatouk; Brouna Safi; Ayad A Jaffa; Rami Mhanna
Journal:  Mater Today Bio       Date:  2022-04-04

7.  Multimodal in vivo imaging of oral cancer using fluorescence lifetime, photoacoustic and ultrasound techniques.

Authors:  Hussain Fatakdawala; Shannon Poti; Feifei Zhou; Yang Sun; Julien Bec; Jing Liu; Diego R Yankelevich; Steven P Tinling; Regina F Gandour-Edwards; D Gregory Farwell; Laura Marcu
Journal:  Biomed Opt Express       Date:  2013-08-26       Impact factor: 3.732

Review 8.  Mass Spectrometry Imaging: A Review of Emerging Advancements and Future Insights.

Authors:  Amanda Rae Buchberger; Kellen DeLaney; Jillian Johnson; Lingjun Li
Journal:  Anal Chem       Date:  2017-12-13       Impact factor: 6.986

9.  Multimodal molecular 3D imaging for the tumoral volumetric distribution assessment of folate-based biosensors.

Authors:  Gerardo J Ramírez-Nava; Clara L Santos-Cuevas; Isaac Chairez; Liliana Aranda-Lara
Journal:  Med Biol Eng Comput       Date:  2017-12-01       Impact factor: 2.602

10.  Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging.

Authors:  Shihong Li; Beth Goins; Lujun Zhang; Ande Bao
Journal:  Bioconjug Chem       Date:  2012-05-22       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.